Advanced filters
Press release
Catherine Woodhead, Chief Executive Officer at Muscular Dystrophy UK, said:
Exondys 51 is not a…
Press release
The study is exciting as it used the technique to boost dystrophin production, key to combatting…
Press release
A £35,000 investment into a rare genetic condition at St Andrews University will ‘bring hope’ to…
News
Researchers at University College London (UCL) have developed artificial ‘mini-muscles’ that could…
Press release
Spinraza is the first and only treatment for patients with the rare inherited muscle-wasting…
News
Acceleron Pharma has announced the US Food and Drug Administration (FDA) has granted Fast Track…
News
The 11th UK Neuromuscular Translational Research Conference was held in Cambridge on 19-20 April…
News
Researchers in Scotland have found that a protein called neurochondrin may play a role in spinal…
News
Summit Therapeutics has announced it has completed dosing participants in its Phase II PhaseOut DMD…
News
Solid Biosciences has announced that the FDA has allowed the high-dose group to be included in the …